Response and outcomes of maintenance avelumab after platinum-based chemotherapy (PBC) in patients (pts) with advanced urothelial carcinoma (aUC): "Real world" experience.

被引：0
|
作者：
Bakaloudi, Dimitra Rafailia
Talukder, Rafee
Makrakis, Dimitrios
Agarwal, Neeraj
Tripathi, Nishita
Bamias, Aristotelis
Zakopoulou, Roubini
Brown, Jason
Korolewicz, James
Fulgenzi, Claudia A. M.
Jindal, Tanya
Murgic, Jure
Frobe, Ana
Johnson, Jeffrey
Drakaki, Alexandra
Rodriguez-Vida, Alejo
Rey-Cardenas, Macarena
Buznego, Lucia Andrea Alonso
Khaki, Ali Raza
Grivas, Petros
机构：
[1] Univ Washington, Seattle, WA USA
[2] Albert Einstein Coll Med, Dept Med, Jacobi Med Ctr, Bronx, NY USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[4] Univ Athens, Athina, Greece
[5] Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Dept Clin Therapeut, Sch Med, Athens, Greece
[6] Univ Hosp Seidman Canc Ctr, Div Oncol, Cleveland, OH USA
[7] Imperial Coll, London, England
[8] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, London, England
[9] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[10] KBC Sestre Milosrdnice, Zagreb, ON, Croatia
[11] Mercy Univ, Zagreb Med Sch, Dept Oncol, Univ Hosp Ctr Sisters, Zagreb, Croatia
[12] Univ Iowa, Div Oncol, Dept Med, Iowa City, IA USA
[13] UCLA, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA USA
[14] Hosp Mar, IMIM Res Inst, Barcelona, Spain
[15] Hosp Univ 12 Octubre, Madrid, Spain
[16] Marque de Valdecilla Univ Hosp, Santander, Spain
[17] Stanford Univ, Stanford, CA USA
[18] Fred Hutchinson Canc Ctr, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
472
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Makrakis, Dimitrios
    Diamantopoulos, Leonidas N.
    Tripathi, Nishita
    Agarwal, Neeraj
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Brown, Jason R.
    Pinato, David J.
    Korolewicz, James
    Jindal, Tanya
    Koshkin, Vadim S.
    Murgic, Jure
    Miletic, Marija
    Frobe, Ana
    Johnson, Jeffrey
    Zakharia, Yousef
    Drakaki, Alexandra
    Rodriguez-Vida, Alejo
    Rey-Cardenas, Macarena
    Castellano, Daniel
    Buznego, Lucia Alonso
    Duran, Ignacio
    Carballeira, Clara Castro
    Barrera, Rafael Morales
    Marmorejo, David
    McKay, Rana R.
    Stewart, Tyler
    Gupta, Shilpa
    Ruplin, Andrew Thomas
    Yu, Evan Y.
    Khaki, Ali R.
    Grivas, Petros
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : 584 - 593
  • [2] Real world outcomes for maintenance avelumab treatment in locally advanced/metastatic urothelial cancer after platinum-based chemotherapy.
    Rehan, Ahmed
    Qureshi, Muneeb
    Aydin, Sabin Goktas
    O'Connor, Kate
    Serra, Maria
    Charnley, Natalie
    Spurgeon, Laura
    Muazzam, Iqtedar
    Bansal, Vikram
    Vasudev, Naveen
    Coe, Faye
    Kagzi, Mohammed Mubashir
    Din, Omar
    Leach, Diane
    Hubbard, Rachel
    Catto, James W. F.
    Hussain, Syed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [3] Real-world response rates and clinical outcomes of patients treated with first-line (1L) platinum-based chemotherapy (PBC) in advanced urothelial cancer (aUC).
    Moon, Helen H.
    Aragon-Ching, Jeanny B.
    Thompson, Allison
    Abraham, Anup
    Vlahiotis, Anna
    Ike, Chiemeka
    Benjumea, Darrin
    Shao, Anran
    Sun, Haiyan
    Kearney, Mairead
    Gharibian, Norbek
    Hanson, Sarah
    Li, Benjamin
    Kirker, Melissa
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy
    Shindo, Tetsuya
    Hashimoto, Kohei
    Takahashi, Atsushi
    Miyamoto, Shintaro
    Kunishima, Yasuharu
    Sato, Shunsuke
    Fukuta, Fumimasa
    Hiyama, Yoshiki
    Takayanagi, Akio
    Kato, Ryuichi
    Wanifuchi, Atsushi
    Ueki, Yohei
    Okada, Manabu
    Adachi, Hideki
    Kobayashi, Ko
    Tanaka, Toshiaki
    Masumori, Naoya
    ANTICANCER RESEARCH, 2024, 44 (03) : 1271 - 1279
  • [5] Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy
    Furubayashi, Nobuki
    Negishi, Takahito
    Sakamoto, Naotaka
    Tamura, Shingo
    Morokuma, Futoshi
    Song, Yoohyun
    Hori, Yoshifumi
    Tomoda, Toshihisa
    Seki, Narihito
    Kuroiwa, Kentaro
    Nakamura, Motonobu
    IN VIVO, 2021, 35 (05): : 2869 - 2874
  • [6] Outcomes in patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV) after switch maintenance avelumab (MAv) in the UNITE study.
    Nizam, Amanda
    Jindal, Tanya
    Jiang, Cindy Y.
    Alhalabi, Omar
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Davidsohn, Matthew P.
    Nguyen, Charles B.
    Oh, Eugene
    Taylor, Amy K.
    Lemke, Emily
    Kilari, Deepak
    Hoimes, Christopher J.
    Emamekhoo, Hamid
    Gupta, Shilpa
    Bellmunt, Joaquim
    Grivas, Petros
    Campbell, Matthew T.
    Alva, Ajjai Shivaram
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 537 - 537
  • [7] REAL-WORLD RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
    Kim, Sandra
    Ma, Josh
    Eigl, Bernie
    Alimohamed, Nimira
    Kulkarni, Girish
    Chung, Peter
    Graham, Jeffrey
    Breau, Rodney
    Ong, Michael
    Levesque, Eric
    Basappa, Naveen
    Rendon, Ricardo
    Castilloux, Jean
    Winquist, Eric
    Siemens, Robert
    Lattouf, Jean-Baptiste
    Mukherjee, Som
    Yokom, Daniel
    Kassouf, Wassim
    Black, Peter
    JOURNAL OF UROLOGY, 2024, 211 (05): : E863 - E863
  • [8] The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
    Bamias, A
    Efstathiou, E
    Moulopoulos, LA
    Gika, D
    Hamilos, G
    Zorzou, MP
    Kakoyiannis, C
    Kastritis, E
    Bozas, G
    Papadimitriou, C
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 307 - 313
  • [9] Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer
    Muto, Satoru
    Abe, Hideyuki
    Noguchi, Takahiro
    Sugiura, Sho-ichiro
    Kitamura, Kousuke
    Isotani, Shuji
    Ide, Hisamitsu
    Yamaguchi, Raizo
    Kamai, Takao
    Horie, Shigeo
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (05) : 490 - 494
  • [10] Efficacy of anti-PD(L)1 therapy for patients (Pts) with advanced urothelial carcinoma (aUC) with primary resistance to platinum-based chemotherapy (PC).
    Stewart, Tyler F.
    Kotha, Nikhil V.
    Dzimitrowicz, Hannah Elizabeth
    Makrakis, Dimitrios
    Khaki, Ali Raza
    Simon, Nicholas I.
    Nelson, Ariel Ann
    Freeman, Dory
    Rose, Tracy L.
    Beck, Wolfgang
    Chawla, Neal Shiv
    Pal, Sumanta K.
    Kilari, Deepak
    Milowsky, Matthew I.
    Apolo, Andrea B.
    Grivas, Petros
    Zhang, Tian
    Sonpavde, Guru P.
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345